{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:56:19Z","timestamp":1791608179356,"version":"4.3.4"},"reference-count":60,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Retinal vein occlusion (RVO) is the second most common retinal vascular disorder after diabetic retinopathy and represents a major cause of visual impairment worldwide. In addition to venous congestion, endothelial dysfunction, and inflammation, accumulating evidence indicates that oxidative stress plays a pivotal role in the pathogenesis of RVO. The excessive production of reactive oxygen species (ROS) during ischemia\u2013reperfusion injury induces endothelial damage, disruption of the blood\u2013retinal barrier, and upregulation of inflammatory cytokines and vascular endothelial growth factor (VEGF), thereby contributing to macular edema and progressive visual dysfunction. This review summarizes current knowledge from both experimental and clinical studies regarding the mechanisms of oxidative stress generation in RVO and its underlying molecular pathways, highlighting the pathological consequences of impaired antioxidant defense systems. We further review reported alterations in oxidative stress markers and antioxidant factors in serum, aqueous humor, and vitreous fluid, and discuss their potential associations with disease activity and visual prognosis. In addition, the interplay between oxidative stress and current standard treatments, including anti-VEGF therapy and corticosteroids, is discussed, together with the translational potential of antioxidant strategies such as polyphenols, vitamins, and Nrf2 pathway activators. At the same time, we address critical challenges limiting clinical application, including insufficient interventional evidence, the lack of validated biomarkers, and uncertainties regarding optimal timing of antioxidant intervention. By providing a comprehensive overview of oxidative stress in RVO, this review aims to identify emerging therapeutic targets and opportunities for personalized treatment approaches, and to outline future research directions toward improving long-term visual outcomes in patients with RVO.<\/jats:p>","DOI":"10.3390\/antiox15030338","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:06:52Z","timestamp":1773054412000},"page":"338","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pathophysiological Roles of Oxidative Stress and the Translational Potential of Antioxidant Therapy in Retinal Vein Occlusion"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6925-3063","authenticated-orcid":false,"given":"Hidetaka","family":"Noma","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Tokyo Medical University Ibaraki Medical Center, Chuo, Amimachi, Inashiki-gun 300-0395, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Mimura","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tsurumi University School of Dental Medicine, Tsurumi, Tsurumi-ku, Yokohama 230-8501, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ophtha.2009.07.017","article-title":"International Eye Disease Consortium. The prevalence of retinal vein occlusion: Pooled data from population studies from the United States, Europe, Asia, and Australia","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0161-6420(83)34530-9","article-title":"Classification of central retinal vein occlusion","volume":"90","author":"Hayreh","year":"1983","journal-title":"Ophthalmology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1538-7836.2010.03909.x","article-title":"Retinal vein thrombosis: Pathogenesis and management","volume":"8","author":"Rehak","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ophtha.2012.09.032","article-title":"Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion","volume":"120","author":"Campochiaro","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Noma, H., Mimura, T., and Shimada, K. (2014). Role of inflammation in previously untreated macular edema with branch retinal vein occlusion. BMC Ophthalmol., 14.","DOI":"10.1186\/1471-2415-14-67"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9208489","DOI":"10.1155\/2017\/9208489","article-title":"Retinal diseases associated with oxidative stress and the effects of a free radical scavenger (edaravone)","volume":"2017","author":"Masuda","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"010427","DOI":"10.7189\/jogh.09.010427","article-title":"Global epidemiology of retinal vein occlusion: A systematic review and meta-analysis of prevalence, incidence, and risk factors","volume":"9","author":"Song","year":"2019","journal-title":"J. Glob. Health"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/08998280.2023.2173938","article-title":"Prevalence and risk factors of retinal vein occlusion in the United States: The National Health and Nutrition Examination Survey, 2005\u20132008","volume":"36","author":"Kalva","year":"2023","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/IAE.0b013e3182870c15","article-title":"Branch retinal vein occlusion: Epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications","volume":"33","author":"Jaulim","year":"2013","journal-title":"Retina"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jtha.2022.10.003","article-title":"Antithrombotic treatment for retinal vein occlusion: A systematic review and meta-analysis","volume":"21","author":"Valeriani","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.2147\/OPTH.S418843","article-title":"Anti-vascular endothelial growth factor therapy with or without initial steroid therapy for macular edema in branch retinal vein occlusion","volume":"17","author":"Noma","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/08820538.2017.1416412","article-title":"Oxidant\u2013antioxidant balance in the aqueous humor of patients with retinal vein occlusion","volume":"33","author":"Altinisik","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s10792-025-03687-z","article-title":"Exploring the role of oxidative stress in retinal vein occlusion: An updated and comprehensive review on the pathophysiology and treatment perspectives","volume":"45","author":"Zhang","year":"2025","journal-title":"Int. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1111\/aos.13892","article-title":"Elevation of serum oxidative stress in patients with retinal vein occlusions","volume":"97","author":"Chen","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/jth.13482","article-title":"Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion","volume":"14","author":"Becatti","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wang, Q., and Zennadi, R. (2020). Oxidative stress and thrombosis during aging: The roles of oxidative stress in RBCs in venous thrombosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124259"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jphotobiol.2014.07.016","article-title":"Docosahexaenoic acid aggravates photooxidative damage in retinal pigment epithelial cells via lipid peroxidation","volume":"140","author":"Liu","year":"2014","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.exer.2018.09.012","article-title":"Light-induced generation and toxicity of docosahexaenoate-derived oxidation products in retinal pigmented epithelial cells","volume":"181","author":"Cheng","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8868564","DOI":"10.1155\/2020\/8868564","article-title":"Hydrogen sulfide protects retinal pigment epithelial cells from oxidative stress-induced apoptosis and affects autophagy","volume":"2020","author":"Hu","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","article-title":"Reperfusion injury and reactive oxygen species: The evolution of a concept","volume":"6","author":"Granger","year":"2015","journal-title":"Redox Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7836828","DOI":"10.1155\/2022\/7836828","article-title":"Role of oxidative stress in retinal disease and the early intervention strategies: A review","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1160\/TH10-07-0499","article-title":"Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: Beneficial effects of iloprost","volume":"105","author":"Lessiani","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Devi, V.L.J., Panigrahi, P.K., Minj, A., and Hanisha, D. (2025). Clinical profile of patients with retinal vein occlusion and its correlation with serum homocysteine levels. BMC Ophthalmol., 25.","DOI":"10.1186\/s12886-025-04285-4"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","article-title":"Homocysteine and vascular disease","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Jiang, H., Zhou, Y., Nabavi, S.M., Sahebkar, A., Little, P.J., Xu, S., Weng, J., and Ge, J. (2022). Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.925923"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.preteyeres.2008.09.001","article-title":"Mitochondrial DNA damage and its potential role in retinal degeneration","volume":"27","author":"Jarrett","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCRESAHA.118.311378","article-title":"Mechanisms of vascular aging","volume":"123","author":"Ungvari","year":"2018","journal-title":"Circ. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Markitantova, Y., and Simirskii, V. (2025). Retinal pigment epithelium under oxidative stress: Chaperoning autophagy and beyond. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031193"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.2147\/IJGM.S522918","article-title":"Diagnostic and prognostic predictive value of serum selenium and redox biomarkers in retinal vein occlusion","volume":"18","author":"Shen","year":"2025","journal-title":"Int. J. Gen. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kumari, N., Cher, J., Chua, E., Hamzah, H., Wong, T.Y., and Cheung, C.Y. (2018). Association of serum lutein and zeaxanthin with quantitative measures of retinal vascular parameters. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203868"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of omega-3 polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ahsanuddin, S., Rios, H.A., Otero-Marquez, O., Macanian, J., Zhou, D., Rich, C., and Rosen, R.B. (2023). Flavoprotein fluorescence elevation is a marker of mitochondrial oxidative stress in patients with retinal disease. Front. Ophthalmol., 3.","DOI":"10.3389\/fopht.2023.1110501"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41598-024-56581-6","article-title":"Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry","volume":"14","author":"Hunt","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"102176","DOI":"10.1016\/j.omtn.2024.102176","article-title":"Inefficacy of anti-VEGF therapy reflected in VEGF-mediated photoreceptor degeneration","volume":"35","author":"Xu","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Lendzioszek, M., Mrugacz, M., Bryl, A., Poppe, E., and Zorena, K. (2023). Prevention and treatment of retinal vein occlusion: The role of diet\u2014A review. Nutrients, 15.","DOI":"10.3390\/nu15143237"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40942-024-00571-3","article-title":"Vitamin D deficiency in patients with retinal vein occlusion: A systematic review and meta-analysis","volume":"10","author":"Daneshvar","year":"2024","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol., 119, 1417\u20131436.","DOI":"10.1001\/archopht.119.10.1417"},{"key":"ref_45","first-page":"800","article-title":"Mitoquinone intravitreal injection ameliorates retinal ischemia\u2013reperfusion injury in rats involving the SIRT1\/Notch1\/NADPH axis","volume":"83","author":"Tang","year":"2022","journal-title":"Drug Dev. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"530943","DOI":"10.1155\/2014\/530943","article-title":"The mitochondria-targeted antioxidant SkQ1 downregulates aryl hydrocarbon receptor-dependent genes in the retina of OXYS rats with AMD-like retinopathy","volume":"2014","author":"Perepechaeva","year":"2014","journal-title":"J. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Pan, H., He, M., Liu, R., Brecha, N.C., Yu, A.C., and Pu, M. (2014). Sulforaphane protects rodent retinas against ischemia-reperfusion injury through activation of the Nrf2\/HO-1 antioxidant pathway. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114186"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chien, J.Y., Chou, Y.Y., Ciou, J.W., Liu, F.Y., and Huang, S.P. (2021). The effects of two Nrf2 activators, bardoxolone methyl and omaveloxolone, on retinal ganglion cell survival during ischemic optic neuropathy. Antioxidants, 10.","DOI":"10.3390\/antiox10091466"},{"key":"ref_49","first-page":"840","article-title":"Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity","volume":"13","author":"Saito","year":"2007","journal-title":"Mol. Vis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"110074","DOI":"10.1016\/j.exer.2024.110074","article-title":"N-acetylcysteine amide and di-N-acetylcysteine amide protect retinal cells in culture via an antioxidant action","volume":"248","author":"Wood","year":"2024","journal-title":"Exp. Eye Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Chronopoulos, P., Manicam, C., Zadeh, J.K., Laspas, P., Unkrig, J.C., G\u00f6bel, M.L., Musayeva, A., Pfeiffer, N., Oelze, M., and Daiber, A. (2023). Effects of resveratrol on vascular function in retinal ischemia-reperfusion injury. Antioxidants, 12.","DOI":"10.3390\/antiox12040853"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"103738","DOI":"10.1016\/j.jpet.2025.103738","article-title":"Recent advances and future challenges in nanosystems for ocular drug delivery","volume":"392","author":"Shahror","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"101883","DOI":"10.1016\/j.redox.2021.101883","article-title":"Retinal oxidative stress activates the NRF2\/ARE pathway: An early endogenous protective response to ocular hypertension","volume":"42","author":"Naguib","year":"2021","journal-title":"Redox Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1167\/iovs.17-22788","article-title":"Animal models of retinal vein occlusion","volume":"58","author":"Khayat","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2147\/OPTH.S307009","article-title":"Antioxidants for the treatment of retinal disease: Summary of recent evidence","volume":"15","author":"Wang","year":"2021","journal-title":"Clin. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1248\/bpb.b22-00846","article-title":"Arctigenin prevents retinal edema in a murine retinal vein occlusion model","volume":"46","author":"Hidaka","year":"2023","journal-title":"Biol. Pharm. Bull."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Long, P., Yan, W., He, M., Zhang, Q., Wang, Z., Li, M., Xue, J., Chen, T., An, J., and Zhang, Z. (2019). Protective effects of hydrogen gas in a rat model of branch retinal vein occlusion via decreasing VEGF-\u03b1 expression. BMC Ophthalmol., 19.","DOI":"10.1186\/s12886-019-1105-2"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Darabu\u015f, D.M., D\u0103r\u0103bu\u015f, R.G., and Munteanu, M. (2025). The diagnosis and treatment of branch retinal vein occlusions: An update. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010105"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.survophthal.2025.08.016","article-title":"Predicting treatment response in retinal vein occlusions using baseline optical coherence tomography biomarkers: A systematic review","volume":"71","author":"Hatamnejad","year":"2026","journal-title":"Surv. Ophthalmol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1573399811666150615151324","article-title":"Anti-VEGF therapy for retinal vein occlusions","volume":"17","author":"Campa","year":"2016","journal-title":"Curr. Drug Targets"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/3\/338\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:10:51Z","timestamp":1773133851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/3\/338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":60,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["antiox15030338"],"URL":"https:\/\/doi.org\/10.3390\/antiox15030338","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]}}}